CATHERINE LOVE: Open Payments
NPI 1437433273 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 16 payments from 11 companies in 2025. Trend: 2023 $780 · 2024 $500 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Amgen Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
Products named: ELIQUIS, LEQVIO, CAMZYOS, VERQUVO, SHINGRIX, REPATHA, Kerendia, MCOT.
Industry payments across KY — which companies pay providers there.
